先天性心脏病患者心脏产科项目正式化后的妊娠相关心脏结局
本研究为美国单中心回顾性队列研究,纳入2002至2020年先天性心脏病(CHD)单胎妊娠超过20周的孕妇,比较心脏产科项目建立前(2002-2010)后(2011-2020)的妊娠结局。项目建立后CHD孕妇数量显著增加,主要复合不良心脏结局无差异,产后利尿剂使用增加。
要点
- 项目建立后CHD孕妇数量增加(200例 vs 84例,占分娩0.48% vs 0.25%,P<.001)。
- 主要复合不良心脏结局无差异(19% vs 17%,P=.64)。
- 产后利尿剂使用增加(4.5% vs 0.0%,P=.04),即使无心力衰竭或肺水肿。
核心结论
- 心脏产科项目建立后,本院分娩的CHD患者数量显著增加,进入妊娠时晚期心力衰竭或系统性心室功能障碍者减少,可能提示孕前心脏保健或孕前咨询改善。
- 复合母体心脏结局相似,但产后利尿剂使用率显著增加,提示产后容量状态受到更多关注。
- CHD与母胎医学的正式合作可能有助于更好地优化患者孕前、孕期和产后的护理。
研究设计与样本
- 回顾性队列研究,纳入2002至2020年美国单城市学术机构中单胎妊娠并继续妊娠超过20周的CHD孕妇。
- 比较心脏产科项目正式建立前(2002-2010)后(2011-2020)的妊娠结局。
主要发现
- 项目后组CHD孕妇数量为200例,项目前组为84例;占所有分娩比例分别为0.48%和0.25%(P<.001)。
- 项目后组引产率高于项目前组(126例[63%] vs 34例[41%],P<.001)。
- 项目后组纽约心脏协会(NYHA)II-IV级患者少于项目前组(23例[12%] vs 17例[22%],P=.04)。
- 项目后组系统性心室功能障碍患者少于项目前组(8例[4%] vs 12例[16%],P=.001)。
- 主要结局无差异(项目后组38例[19%] vs 项目前组14例[17%],P=.64),校正混杂因素后 adjusted odds ratio 为2.3(95% confidence interval 0.96-5.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of pregnant patients with congenital heart disease (CHD) is increasing, and these patients are at high risk for cardiac morbidity. OBJECTIVE: This study aimed to examine the pregnancy outcomes in patients with congenital heart disease before and after the establishment of formal cardio-obstetrics collaboration between adult congenital heart disease and maternal-fetal medicine programs. STUDY DESIGN: This was a retrospective cohort study of pregnant patients with congenital heart disease from 2002 to 2020 at a single urban academic institution in the United States. This study included patients with a singleton pregnancy who continued a pregnancy beyond 20 weeks of gestation. The primary outcome was a composite adverse maternal cardiac outcome, compared before (2002-2010) and after (2011-2020) the program. The secondary outcomes included gestational age at delivery, mode of delivery, rate of labor induction, use of diuresis after delivery, and a composite maternal morbidity outcome. RESULTS: The number of pregnant patients with congenital heart disease increased after formalization of the cardio-obstetrics program (200 [postprogram group] vs 84 [preprogram group]; 0.48% of all deliveries in the postprogram group vs 0.25% of all deliveries in the preprogram group; P<.001). The postprogram group was more likely to undergo labor induction than the preprogram group (126 [63%] vs 34 [41%], respectively; P<.001). There were fewer patients in the postprogram group than in the preprogram group who were New York Heart Association class II to IV (23 [12%] vs 17 [22%], respectively; P=.04) or with systemic ventricular dysfunction (8 [4%] vs 12 [16%], respectively; P=.001). There was no difference in the primary outcome (38 [19%] in the postprogram group vs 14 [17%] in the preprogram group; P=.64), even after adjusting for confounders, including New York Heart Association class >I and systemic ventricular dysfunction (adjusted odds ratio, 2.3; 95% confidence interval, 0.96-5.4). Patients in the postprogram group were more likely to receive diuresis after delivery than patients in the preprogram group, even in the absence of heart failure or pulmonary edema (9 [4.5%] vs 0 [0.0%], respectively; P=.04). CONCLUSION: In the period after the establishment of a formal cardio-obstetrics program between adult congenital heart disease and maternal-fetal medicine, the number of patients with congenital heart disease delivering at our institution increased significantly. Overall, fewer patients entered pregnancy with advanced-stage heart failure or systemic ventricular dysfunction, possibly suggesting improved prepregnancy cardiac care or improved preconception counseling. Composite maternal cardiac outcomes were similar, but the rates of postpartum diuresis increased significantly, suggesting increased attention to volume status in the postpartum period. Formalized collaboration between congenital heart disease and maternal-fetal medicine may help better optimize patients' care before conception, during pregnancy, and after delivery.
引用
- McCoy JA, Kim YY, Nyman A, et al. Pregnancy-related cardiac outcomes among patients with congenital heart disease after formalization of a cardio-obstetrics program. Am J Obstet Gynecol MFM. 2024. PMID: 38460824. doi:10.1016/j.ajogmf.2024.101335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。